BDBM345256 2-[[5-(4-Chlorophenyl)-1-[(4- chlorophenyl)methyl[pyrazol-3- yl]methoxy]-2-methyl-propanoic acid 1H NMR (CD3OD, 400 MHz) $#948; 1.52 (s, 6H), 4.54 (s, 2H0, 5.329s, 2H), 6.48 (s, 1H), 6.91-7.00 (m, 1H), 7.21-7.30-(m, 2H), 7.31-7.38 (m, 2H), 7.40-7.48 (m 3H).::US10202350, Example 2::US10214492, Example 2::US11292767, Example 2::US11724989, Example 2

SMILES CC(C)(OCc1cc(-c2ccc(Cl)cc2)n(Cc2ccc(Cl)cc2)n1)C(O)=O

InChI Key InChIKey=CRCDAXQBKNUOJO-UHFFFAOYSA-N

Data  11 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 345256   

TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345256(2-[[5-(4-Chlorophenyl)-1-[(4- chlorophenyl)methyl...)
Affinity DataIC50:  2.90E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent